HB 4451, the Veteran Justice Act, creates a program allowing eligible veterans charged with certain offenses to avoid a criminal conviction or have a felony reduced to a misdemeanor. It applies to veterans with military-related conditions like PTSD, TBI, or substance use disorder (SUD) that contributed to their offense, provided the crime is probation-eligible and not excluded (e.g., murder, sexual assault). Eligible veterans enter a court-supervised program involving evidence-based treatment tailored to their military service challenges, a personalized case plan, and probation instead of incarceration. If they successfully complete the plan, they avoid conviction; failure results in standard sentencing. The bill excludes serious crimes like human trafficking and requires verification of veteran status using federal databases like SQUARES.
HB 4196 requires licensed medication-assisted treatment (MAT) programs in West Virginia to offer long-acting reversible contraception (LARC), such as IUDs or implants, to patients receiving methadone or suboxone for substance use treatment. This applies to all facilities providing these services under the state's licensing framework, adding it as a standard requirement to existing operational rules. The bill directly affects MAT facilities, which must now integrate LARC options into their care protocols, and patients using methadone or suboxone at these locations. It creates a concrete policy change by mandating access to these contraceptive methods without requiring additional patient steps.
This bill establishes a value-based payment system for West Virginia's Medicaid addiction care services, shifting from fee-for-service to rewarding providers based on patient recovery outcomes. It directly affects Medicaid providers treating substance use disorders by requiring them to use standardized billing codes starting in 2027 and report on five specific outcome metrics: housing stability, sobriety, avoidance of criminal justice involvement, self-sufficiency (employment/education), and provider transition plans. The bill mandates data collection and analysis by the Bureau for Medical Services to develop these metrics, with value-based payments requiring implementation by 2028. The goal is to create a coordinated care system focused on long-term recovery success rather than fragmented service volume.
HB 4458, known as "Joel’s Law," creates a legal process for involuntary treatment of individuals with substance use disorders who pose an imminent danger to themselves or others. It requires a petition from a family member, friend, or guardian to a West Virginia Circuit Court, accompanied by a guarantee to cover treatment costs, and sets strict criteria: the person must have a substance use disorder, present an immediate danger, and be likely to benefit from treatment. The bill establishes a 72-hour emergency treatment option and a formal court process for 60- to 360-day treatment orders, including medical examinations and a hearing within 14 days. This law directly affects individuals meeting these specific danger criteria and their families, while ensuring procedural safeguards like court oversight and cost accountability.
HB 4032 would establish quick response teams (QRTs) under West Virginia's Office of Drug Control Policy to assist individuals with substance use disorders who are arrested and experiencing drug-related medical emergencies. These teams would provide immediate support and connect arrested individuals to treatment options at regional jails or treatment facilities, working directly with law enforcement and health services. The bill requires the Office of Drug Control Policy to develop this program by coordinating with health care providers, emergency services, and law enforcement, effective July 1, 2026. This policy change aims to create a direct pathway to recovery for people with substance use disorders following an arrest.
SB 361 authorizes the West Virginia Board of Pharmacy to implement a rule regarding pharmacist recovery networks, which are programs enabling pharmacists to provide medication-assisted treatment for opioid use disorder. The rule, previously drafted and modified to address legislative concerns, is now formally approved by law. This procedural bill directly affects pharmacists and pharmacies by allowing the Board to establish standards for participation in recovery networks. It does not alter the rule's content but enables its implementation as part of pharmacy practice regulations.
HB 4626 establishes a West Virginia grant program to fund U.S. Food and Drug Administration (FDA) drug development trials using ibogaine, a substance being studied for treating opioid use disorder and other neurological/mental health conditions. The program requires applicants (e.g., pharmaceutical companies or research organizations) to demonstrate capacity to conduct FDA trials, secure approval for ibogaine as a medication, and commit to establishing a state presence, securing insurance coverage, and ensuring treatment access for uninsured patients. Applicants must submit detailed trial designs, safety protocols, and plans for intellectual property rights and post-approval implementation, with grants administered through a state selection committee. The bill does not approve ibogaine but aims to accelerate its development pathway through state-funded trials.
SB 565 requires West Virginia's Public Employees Insurance Agency (PEIA) and other health insurance providers to pay behavioral health, mental health, and substance use disorder providers the same rate as medical/surgical providers for comparable services. This applies to licensed practitioners (e.g., psychologists, counselors) who submit claims with standard diagnostic codes, provider IDs, and facility details. Insurers cannot reduce physician reimbursements to comply with this rule or apply stricter non-quantitative limits to behavioral health care than to medical care. The bill directly affects behavioral health providers by ensuring equal payment for services previously subject to lower reimbursement rates.
HB 4826 establishes a legal process for involuntary treatment of individuals with substance use disorders in West Virginia. It directly affects people who meet strict criteria (having a substance use disorder, posing an imminent danger to self/others, and likely benefiting from treatment) and their family members or friends who file petitions. Key provisions require verified petitions from petitioners (like spouses or relatives) guaranteeing treatment costs, court hearings within 72 hours, and medical evaluations by qualified professionals before ordering 60-day or 360-day treatment. The bill also creates a 72-hour emergency hospitalization option for immediate danger, requiring court approval based on strong evidence. All procedures must follow specific court oversight to protect patient rights.
HB 4336 sets new operational standards for medication-assisted treatment (MAT) programs in West Virginia. It requires all MAT programs to have a licensed medical director who meets specific training and practice requirements, and mandates qualified counseling staff with defined certifications (e.g., licensed psychiatrists, certified addiction counselors). Programs must follow new billing rules, including obtaining written insurance denial before charging patients directly for treatment, and must document patient insurance status. These requirements apply to all MAT programs seeking state licensing or Medicaid enrollment.
